← 返回

Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.

Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.

期刊: Science advances 日期: 2026-08-28 PMID: 42647644 DOI: 10.1126/sciadv.aef6065 浏览: 13
作者: Zhang RM, Zhu X, Bae H, Zhang J, Li Y, Chen PY, Shen YH, Tellides G, Snyder N, Jang C
RM, Z., X, Z., H, B., J, Z., Y, L., PY, C., YH, S., G, T., N, S., & C, J. (2026). Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.. Science advances. https://doi.org/10.1126/sciadv.aef6065
RM Z, X Z, H B, J Z, Y L, PY C, et al. Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.. Science advances. 2026; doi: 10.1126/sciadv.aef6065
RM Z, X Z, H B, et al. Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.[J]. Science advances. 2026. DOI: 10.1126/sciadv.aef6065.
@article{rm2026,
  author = {Zhang RM and Zhu X and Bae H and Zhang J and Li Y and Chen PY and Shen YH and Tellides G and Snyder N and Jang C},
  title = {Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.},
  journal = {Science advances},
  year = {2026},
  doi = {10.1126/sciadv.aef6065},
  note = {PMID: 42647644},
}
TY  - JOUR
AU  - Zhang RM
AU  - Zhu X
AU  - Bae H
AU  - Zhang J
AU  - Li Y
AU  - Chen PY
AU  - Shen YH
AU  - Tellides G
AU  - Snyder N
AU  - Jang C
TI  - Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.
T2  - Science advances
PY  - 2026
DO  - 10.1126/sciadv.aef6065
AN  - PMID:42647644
ER  - 

摘要

The loss of smooth muscle cell (SMC) contractile phenotype contributes to various diseases including atherosclerosis. However, its metabolic basis is not entirely elucidated. Since the transforming growth factor beta (TGFβ) signaling is among principal regulators of SMC contractility, we studied metabolic regulation of TGFβ signaling in SMCs in vitro and atherosclerotic mouse models and human lesions. We found that TGFβ induced Ac-CoA synthetase 2 (ACSS2)-dependent Ac-CoA production, by suppressing pyruvate dehydrogenase kinase 4 (PDK4). This stabilized R-SMADs and TGFβ receptor 1, preserving SMC contractile phenotype. SMC-specific PDK4 knockout mimicked the effect of TGFβ signaling both metabolically and phenotypically, increasing glucose-derived synthesis of Ac-CoA and SMC contractile phenotype. SMC-specific Pdk4 knockout in ApoE knockout mice reduced atherosclerosis. Furthermore, human specimens demonstrated a strong correlation between PDK4 level and atherosclerosis severity. These findings indicate that continuous SMC TGFβ signaling, critical to the maintenance of the normal SMC contractile state, is regulated by PDK4 and carbohydrate metabolism.

AI 智能解读

相关文献

返回分类: 动脉粥样硬化 查看原文 (DOI)
已选择 0 篇文献